IDO1 and breast cancer: Our study demonstrated that the dihydropyridine antihypertensive drug lacidipine acts as a bifunctional modulator of IDO and is involved in IDO‐mediated tumor immunity by inhibiting both the expression and enzymatic activity of IDO in breast cancer.